Literature DB >> 9879944

Serotype variation in Streptococcus anginosus, S. constellatus and S. intermedius.

M Inoue1, H Eifuku-Koreeda, K Kitada, N Takamatsu-Matsushita, Y Okada, E Osano.   

Abstract

Various serotypes reported in three serotyping systems for the 'Streptococcus milleri' group, i.e., Ottens I-IV, Osano I-IV and serotypes a-k, were compared with each other in a capillary precipitation test and by the double immunodiffusion test. Only two of the 19 serotypes, f and Ottens-III, were identical, and the other 17 serotypes were independent. Thus, 18 serotypes and another three candidates (a-, b- and g-cross-reactive) were found in the 'S. milleri' group. Of the 248 strains tested, 197 were serotypable, and 23 strains carried two type antigens. Generally, the Ottens I, II, III (serotype f), IV and Osano IV antigens, often together with the Lancefield group F antigen, were found in S. anginosus and S. constellatus. In addition, the serotype a, c, d, e and k antigens with the group A, C or G antigen were distributed in S. anginosus, the serotype b antigen in S. constellatus and the g, h, i, j, Osano I, II and III antigens in S. intermedius. Twenty-five of the untypable strains were Lancefield groupable (mostly F).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879944     DOI: 10.1099/00222615-47-5-435

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.

Authors:  C M Brandt; G Haase; N Schnitzler; R Zbinden; R Lütticken
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Rapid differentiation between members of the anginosus group and Streptococcus dysgalactiae subsp. equisimilis within beta-hemolytic group C and G streptococci by PCR.

Authors:  Liang-Chun Liu; Jui-Chang Tsai; Po-Ren Hsueh; Lee-Jene Teng
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.